Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

PDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.

Kartha VK, Stawski L, Han R, Haines P, Gallagher G, Noonan V, Kukuruzinska M, Monti S, Trojanowska M.

PLoS One. 2016 Apr 29;11(4):e0154645. doi: 10.1371/journal.pone.0154645. eCollection 2016.

2.

Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Berndt A, Richter P, Kosmehl H, Franz M.

Cell Adh Migr. 2015;9(1-2):105-11. doi: 10.1080/19336918.2015.1005463. Review.

3.

Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers.

Santoro A, Pannone G, Papagerakis S, McGuff HS, Cafarelli B, Lepore S, De Maria S, Rubini C, Mattoni M, Staibano S, Mezza E, De Rosa G, Aquino G, Losito S, Loreto C, Crimi S, Bufo P, Lo Muzio L.

Biomed Res Int. 2014;2014:948264. doi: 10.1155/2014/948264. Epub 2014 Jan 8.

4.

Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.

Aquino G, Sabatino R, Cantile M, Aversa C, Ionna F, Botti G, La Mantia E, Collina F, Malzone G, Pannone G, Losito NS, Franco R, Longo F.

Biomed Res Int. 2013;2013:736438. doi: 10.1155/2013/736438. Epub 2013 Dec 16.

5.

TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.

Wu X, Cao W, Wang X, Zhang J, Lv Z, Qin X, Wu Y, Chen W.

Mol Cancer. 2013 Dec 1;12(1):151. doi: 10.1186/1476-4598-12-151.

6.

Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice.

Tao X, Hill KS, Gaziova I, Sastry SK, Qui S, Szaniszlo P, Fennewald S, Resto VA, Elferink LA.

Oral Oncol. 2014 Feb;50(2):104-12. doi: 10.1016/j.oraloncology.2013.10.014. Epub 2013 Nov 21.

7.

A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology.

Kolokythas A, Bosman MJ, Pytynia KB, Panda S, Sroussi HY, Dai Y, Schwartz JL, Adami GR.

J Oral Pathol Med. 2013 Oct;42(9):663-9. doi: 10.1111/jop.12068. Epub 2013 Apr 17.

8.

Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.

Vincent-Chong VK, Anwar A, Karen-Ng LP, Cheong SC, Yang YH, Pradeep PJ, Rahman ZA, Ismail SM, Zaini ZM, Prepageran N, Kallarakkal TG, Ramanathan A, Mohayadi NA, Rosli NS, Mustafa WM, Abraham MT, Tay KK, Zain RB.

PLoS One. 2013;8(2):e54705. doi: 10.1371/journal.pone.0054705. Epub 2013 Feb 6.

9.

In vivo optical imaging of tumor and microvascular response to ionizing radiation.

Maeda A, Leung MK, Conroy L, Chen Y, Bu J, Lindsay PE, Mintzberg S, Virtanen C, Tsao J, Winegarden NA, Wang Y, Morikawa L, Vitkin IA, Jaffray DA, Hill RP, DaCosta RS.

PLoS One. 2012;7(8):e42133. doi: 10.1371/journal.pone.0042133. Epub 2012 Aug 22.

10.

Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma.

He Q, Wei J, Zhang J, Jiang H, Wang S, Zhou X, Zhang Z, Huang G, Watanabe H, Su J.

Oncol Lett. 2011 Jul;2(4):725-729. Epub 2011 May 5.

11.

Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.

Schutt C, Bumm K, Mirandola L, Bernardini G, D'Cunha N, Tijani L, Nguyen D, Cordero J, Jenkins MR, Cobos E, Kast WM, Chiriva-Internati M.

Int Rev Immunol. 2012 Feb;31(1):22-42. doi: 10.3109/08830185.2011.637253. Review.

12.

The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.

Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, Tan J, Cao Y, Tsao SW, Srivastava G, Chan AT, Tao Q.

Oncogene. 2012 Aug 23;31(34):3901-12. doi: 10.1038/onc.2011.541. Epub 2011 Dec 5.

13.

Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.

Elferink LA, Resto VA.

J Signal Transduct. 2011;2011:982879. doi: 10.1155/2011/982879. Epub 2011 Jun 7.

14.

Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.

Cao W, Zhang ZY, Xu Q, Sun Q, Yan M, Zhang J, Zhang P, Han ZG, Chen WT.

Mol Cancer. 2010 Nov 22;9:296. doi: 10.1186/1476-4598-9-296.

15.

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Arnold SA, Rivera LB, Miller AF, Carbon JG, Dineen SP, Xie Y, Castrillon DH, Sage EH, Puolakkainen P, Bradshaw AD, Brekken RA.

Dis Model Mech. 2010 Jan-Feb;3(1-2):57-72. doi: 10.1242/dmm.003228. Epub 2009 Dec 9.

16.

2D-DIGE proteomic characterization of head and neck squamous cell carcinoma.

Merkley MA, Weinberger PM, Jackson LL, Podolsky RH, Lee JR, Dynan WS.

Otolaryngol Head Neck Surg. 2009 Nov;141(5):626-32. doi: 10.1016/j.otohns.2009.08.011.

17.

SPARC: a matricellular regulator of tumorigenesis.

Arnold SA, Brekken RA.

J Cell Commun Signal. 2009 Dec;3(3-4):255-73. doi: 10.1007/s12079-009-0072-4. Epub 2009 Oct 7.

18.

Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution.

Huttlin EL, Chen X, Barrett-Wilt GA, Hegeman AD, Halberg RB, Harms AC, Newton MA, Dove WF, Sussman MR.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17235-40. doi: 10.1073/pnas.0909282106. Epub 2009 Sep 23.

19.

Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder.

Rani S, Barbe MF, Barr AE, Litvin J.

J Histochem Cytochem. 2009 Nov;57(11):1061-73. doi: 10.1369/jhc.2009.954081. Epub 2009 Jul 20.

20.

A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.

Méndez E, Houck JR, Doody DR, Fan W, Lohavanichbutr P, Rue TC, Yueh B, Futran ND, Upton MP, Farwell DG, Heagerty PJ, Zhao LP, Schwartz SM, Chen C.

Clin Cancer Res. 2009 Feb 15;15(4):1353-61. doi: 10.1158/1078-0432.CCR-08-1816.

Supplemental Content

Support Center